echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > US Centers for Disease Control report: Pfizer, Modena vaccines may be related to young people suffering from myocarditis

    US Centers for Disease Control report: Pfizer, Modena vaccines may be related to young people suffering from myocarditis

    • Last Update: 2021-08-08
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    A consultant doctor from the Centers for Disease Control and Prevention (CDC) issued a report on Wednesday (23rd) that Pfizer's new crown vaccine and Modena's new crown vaccine may be related to rare cases of heart inflammation in young people


    According to Fox News on the 23rd, the report was published by the New Coronary Pneumonia Vaccine Safety Technical Working Group under the CDC


    According to reports, both Pfizer and Modena vaccines belong to messenger ribonucleic acid (mRNA) technology vaccines


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.